- Previous Close
8.12 - Open
8.12 - Bid 8.13 x 800
- Ask 8.14 x 800
- Day's Range
8.09 - 8.29 - 52 Week Range
5.95 - 14.04 - Volume
349,107 - Avg. Volume
790,615 - Market Cap (intraday)
404.992M - Beta (5Y Monthly) 1.04
- PE Ratio (TTM)
-- - EPS (TTM)
-2.95 - Earnings Date May 6, 2025 - May 12, 2025
- Forward Dividend & Yield 0.24 (2.96%)
- Ex-Dividend Date Feb 24, 2025
- 1y Target Est
7.50
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
www.nuskin.com3,100
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NUS
View More
Performance Overview: NUS
Trailing total returns as of 3/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NUS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NUS
View MoreValuation Measures
Market Cap
403.75M
Enterprise Value
683.98M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.23
Price/Book (mrq)
0.62
Enterprise Value/Revenue
0.39
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-8.46%
Return on Assets (ttm)
3.42%
Return on Equity (ttm)
-19.90%
Revenue (ttm)
1.73B
Net Income Avi to Common (ttm)
-146.59M
Diluted EPS (ttm)
-2.95
Balance Sheet and Cash Flow
Total Cash (mrq)
206.66M
Total Debt/Equity (mrq)
73.41%
Levered Free Cash Flow (ttm)
142.12M
Research Analysis: NUS
View MoreCompany Insights: NUS
NUS does not have Company Insights
Research Reports: NUS
View MoreWhat does Argus have to say about NUS?
NU SKIN ENTERPRISES INC - A has an Investment Rating of SELL; a target price of $6.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetRating decreased to a SELL
NU SKIN ENTERPRISES INC - A has an Investment Rating of SELL; a target price of $6.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice TargetLowering target price to $7.00
NU SKIN ENTERPRISES INC - A has an Investment Rating of HOLD; a target price of $7.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
RatingPrice TargetWhat does Argus have to say about NUS?
NU SKIN ENTERPRISES INC - A has an Investment Rating of HOLD; a target price of $10.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice Target